Gen-Probe Withdraws from Previously Announced Investor Presentations
SAN DIEGO, May 3, 2012 /PRNewswire/ -- Gen-Probe Incorporated (GPRO) (NASDAQ: GPRO) announced today that the Company has withdrawn from the following three upcoming investor conferences previously announced on April 26, 2012, and therefore will not webcast presentations at any of these investor conferences:
- Deutsche Bank 37th Annual Health Care Conference in Boston on May 8 at 1:30 p.m. Eastern Time;
- Baird's 2012 Growth Stock Conference in Chicago on May 9 at 3:40 p.m. Central Time; and
- Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas on May 15 at 4:20 p.m. Pacific Time.
Gen-Probe is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. Gen-Probe is headquartered in San Diego and employs approximately 1,400 people. For more information, go to http://www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions, or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results to differ materially from those expressed or implied. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including our most recent Form 10-K, and all subsequent periodic filings. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.
SOURCE Gen-Probe Incorporated